Adverse drug reactions to local anaesthetics: A review of the French pharmacovigilance database

Drug Safety

Volumn 32, Issue 4, 2009, Pages 345-356

  Fuzier, Regis ^a   Lapeyre Mestre, Maryse ^a,b   Samii, Kamran ^a   Montastruc, Jean Louis ^a,b  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; LEVOBUPIVACAINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MEPIVACAINE; ROPIVACAINE;

ADULT; AGED; AGITATION; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ARTICLE; ASYSTOLE; BRADYCARDIA; BRONCHOSPASM; CHILD; CONFUSION; DISEASE SEVERITY; DROWSINESS; DRUG ERUPTION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; DYSARTHRIA; DYSPNEA; ECZEMA; EDEMA; ERYTHEMA; FEMALE; HEART ARREST; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOTENSION; KIDNEY FAILURE; LIVER FAILURE; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; NECK EDEMA; NEUROLOGIC DISEASE; NEWBORN; PANCREATITIS; PARALYSIS; PERIPHERAL NERVE INJURY; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; SEIZURE; SHOCK; SIDE EFFECT; SPINAL ANESTHESIA; SYNCOPE; TACHYCARDIA; THORAX PAIN; TREATMENT FAILURE; URTICARIA;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ANESTHETICS, LOCAL; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; FRANCE; HEART ARREST; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; POPULATION SURVEILLANCE; PRODUCT SURVEILLANCE, POSTMARKETING; SEIZURES;

EID: 65949123369     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200932040-00008     Document Type: Article

References (40)

1. Clergue F, Auroy Y, Pequignot F, et al. French survey of anesthesia in 1996. Anesthesiology 1999 Nov; 91 (5): 1509-20
2. Enneking FK, Chan V, Greger J, et al. Lower-extremity peripheral nerve blockade: essentials of our current understanding. Reg Anesth Pain Med 2005 Jan; 30 (1): 4-35
3. Fuzier R, Cuvillon P, Delcourt J, et al. Peripheral nerve block in orthopaedic surgery: multicentric evaluation of practicing professionnels and impact on the activity of the recovery room. Ann Fr Anesth Reanim 2007 Sep; 26 (9): 761-8
4. Hadzic A, Vloka JD, Kuroda MM, et al. The practice of peripheral nerve blocks in the United States: a national survey. Reg Anesth Pain Med 1998 May; 23 (3): 241-6
5. Klein SM, Pietrobon R, Nielsen KC, et al. Peripheral nerve blockade with long-acting local anesthetics: a survey of the Society for Ambulatory Anesthesia. Anesth Analg 2002 Jan; 94 (1): 71-6
6. Horlocker TT, Neal JM. One hundred years later, I can still make your heart stop and your legs weak: the relationship between regional anesthesia and local anesthetic toxicity. Reg Anesth Pain Med 2002 Nov; 27 (6): 543-4
7. Horlocker TT, McGregor DG, Matsushige DK, et al. A retrospective review of 4767 consecutive spinal anesthetics: central nervous system complications. Perioperative Outcomes Group. Anesth Analg 1997 Mar; 84 (3): 578-84
8. Auroy Y, Benhamou D, Bargues L, et al. Major complications of regional anesthesia in France: the SOS Regional Anesthesia Hotline Service. Anesthesiology 2002 Nov; 97 (5): 1274-80
9. De Tommaso O, Caporuscio A, Tagariello V. Neurological complications following central neuraxial blocks: are there predictive factors? Eur J Anaesthesiol 2002 Oct; 19 (10): 705-16
10. Carpenter RL, Caplan RA, Brown DR, et al. Incidence and risk factors for side effects of spinal anesthesia. Anesthesiology 1992 Jun; 76 (6): 906-16
11. Bergman BD, Hebl JR, Kent J, et al. Neurologic complications of 405 consecutive continuous axillary catheters. Anesth Analg 2003 Jan; 96 (1): 247-52
12. Srinivasa V, Gerner P, Haderer A, et al. The relative toxicity of amitriptyline, bupivacaine, and levobupivacaine administered as rapid infusions in rats. Anesth Analg 2003 Jul; 97 (1): 91-5
13. Borgeat A, Ekatodramis G, Kaberer F, et al. Acute and nonacute complications associated with interscalene block and shoulder surgery: a prospective study. Anesthesiology 2001 Oct; 95 (4): 875-80
14. Bisschop DY, Alardo JP, Razgallah B, et al. Seizure induced by ropivacaine. Ann Pharmacother 2001 Mar; 35 (3): 311-3
15. Breslin DS, Martin G, Macleod DB, et al. Central nervous system toxicity following the administration of levobupivacaine for lumbar plexus block: a report of two cases. Reg Anesth Pain Med 2003 Mar; 28 (2): 144-7
16. Crews JC, Rothman TE. Seizure after levobupivacaine for interscalene brachial plexus block. Anesth Analg 2003 Apr; 96 (4): 1188-90
17. Dernedde M, Furlan D, Verbesselt R, et al. Grand mal convulsion after an accidental intravenous injection of ropivacaine. Anesth Analg 2004 Feb; 98 (2): 521-3
18. Mullanu C, Gaillat F, Scemama F, et al. Acute toxicity of local anesthetic ropivacaine and mepivacaine during a combined lumbar plexus and sciatic block for hip surgery. Acta Anaesthesiol Belg 2002; 53 (3): 221-3
19. Graf BM. The cardiotoxicity of local anesthetics: the place of ropivacaine. Curr Top Med Chem 2001 Aug; 1 (3): 207-14
20. Foxall G, McCahon R, Lamb J, et al. Levobupivacaineinduced seizures and cardiovascular collapse treated with Intralipid. Anaesthesia 2007 May; 62 (5): 516-8
21. Faccenda KA, Finucane BT. Complications of regional anaesthesia incidence and prevention. Drug Saf 2001; 24 (6): 413-42
22. Local anesthetics. In: Aronson JK, editor. Meyler's side effects of drugs: the international encyclopedia of adverse drug reactions and interactions. Amsterdam: Elsevier, 2006: 2116-57
23. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356 (9237): 1255-9
24. Begaud B, Evreux JC, Jouglard J, et al. Unexpected or toxic drug reaction assessment (imputation): actualization of the method used in France. Therapie 1985; 40: 111-8
25. International Conference on Harmonisation: guidance on addendum to E2C clinical safety data management. Periodic safety update reports for marketed drugs; availability. Notice. Fed Regist 2004 Feb; 69 (24): 5551-2
26. Weber JCP. Epidemiology of adverse reactions to nonsteroidal antiinflammatory drugs. In:Rainsford KD, Velo GP, editors. Advances in inflammatory research. New York: Raven Press, 1984: 1-7
27. French Society of Regional Anesthesia and Intensive Care. Peripheral nerve block of limbs in the adult. Ann Fr Anesth Reanim 2003 Jun; 22 (6): 567-81
28. Thiessard F, Roux E, Miremont-Salame G, et al. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001). Drug Saf 2005; 28 (8): 731-40
29. Hoppe J, Popham P. Complete failure of spinal anaesthesia in obstetrics. Int J Obstet Anesth 2007 Jul; 16 (3): 250-5
30. Hebl JR, Kopp SL, Schroeder DR, et al. Neurologic complications after neuraxial anesthesia or analgesia in patients with preexisting peripheral sensorimotor neuropathy or diabetic polyneuropathy. Anesth Analg 2006 Nov; 103 (5): 1294-9
31. Lacassie HJ, Muir HA, Millar S, et al. Perioperative anesthetic management for Cesarean section of a parturient with gestational diabetes insipidus. Can J Anaesth 2005 Aug; 52 (7): 733-6
32. Kelly D, Gudin JA, Brull SJ. Subcutaneous cysts: another cause of "failed" spinal anesthesia? J Clin Anesth 1996 Nov; 8 (7): 603-4
33. Carpenter RL, Hogan QH, Liu SS, et al. Lumbosacral cerebrospinal fluid volume is the primary determinant of sensory block extent and duration during spinal anesthesia. Anesthesiology 1998 Jul; 89 (1): 24-9
34. Munhall RJ, Sukhani R,Winnie AP. Incidence and etiology of failed spinal anesthetics in a university hospital: a prospective study. Anesth Analg 1988 Sep; 67 (9): 843-8
35. Brown DL, Ransom DM, Hall JA, et al. Regional anesthesia and local anesthetic-induced systemic toxicity: seizure frequency and accompanying cardiovascular changes. Anesth Analg 1995 Aug; 81 (2): 321-8
36. Berman RS, Eisele JH. Bacteremia, spinal anesthesia, and development of meningitis. Anesthesiology 1978 May; 48 (5): 376-7
37. Burke D, Wildsmith JA.Meningitis after spinal anaesthesia. Br J Anaesth 1997 Jun; 78 (6): 635-6
38. Begaud B, Martin K, Haramburu F, et al. Rates of spontaneous reporting of adverse drug reactions in France [letter]. JAMA 2002 Oct; 288 (13): 1588
39. Belton KJ. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union: the European Pharmacovigilance Research Group. Eur J Clin Pharmacol 1997; 52 (6): 423-7
40. Pierfitte C, Begaud B, Lagnaoui R, et al. Is reporting rate a good predictor of risks associated with drugs? Br J Clin Pharmacol 1999 Mar; 47 (3): 329-31